Clinical Trial Update: An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tanezumab for pain associated with chronic prostatitis with chronic pelvic pain syndrome has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostatitis with Chronic Pelvic Pain Syndrome

Drugs mentioned

• Tanezumab (tanezumab)

Snippet

Sponsor: Pfizer | Conditions: Chronic Prostatitis With Chronic Pelvic Pain Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2021-05-13